SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharmaceuticals gets product approval for Tamoxifen tablet in South Africa

24 Dec 2024 Evaluate

Kwality Pharmaceuticals has successfully obtained product approval in South Africa (SAHPRA) for its prominent oncology oral solid dosage (OSD) product, Tamoxifen 20mg Tablet, through a site transfer process. 

This approval is a significant achievement in expanding the availability of this critical therapeutic, which plays a vital role in the treatment of hormone receptor-positive breast cancer. It reflects its ongoing commitment to providing high-quality, accessible oncology treatments to patients in key markets. This approval further strengthens its presence in the High Regulated and global oncology market.

Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company.


Kwality Pharma Share Price

1618.95 35.20 (2.22%)
22-Apr-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1657.70
Dr. Reddys Lab 1213.25
Cipla 1227.75
Zydus Lifesciences 927.65
Lupin 2305.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×